PARP Inhibitors Market: Current Analysis and Forecast (2024-2032)

Ajouter une nouvelle offre d'emploi Autre

2024-09-12 06:07:10 - Traduire

Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a revolutionary class of drugs in the treatment of cancer, majorly ovarian, breast, and prostate cancers. The demand for PARP inhibitors has grown subsequently in past few years, driven by their unique mechanism of action which exploits cancer cells' DNA repair weaknesses. This blog delves into the rising clinical trials and...

0 Commentaires 0 Parts 3KB Vue 0 Aperçu